Group 1 - The core viewpoint of the article highlights CVS Health's financial performance, showing a revenue increase but a decline in net profit for the fiscal year ending June 30, 2025 [1][2] - CVS Health reported total revenue of $193.5 billion, representing a year-on-year growth of 7.7% [1] - The company's net profit attributable to shareholders was $2.8 billion, which is a decrease of 2.88% compared to the previous year [2] Group 2 - As of July 31, CVS Health's stock opened at $66.00 per share, with a trading volume of $87.77 million and a total market capitalization of $83.71 billion [1] - CVS Health is recognized as the largest pharmaceutical retailer in the United States, focusing on pharmaceutical innovation to improve health outcomes [2] - The company has established various innovative operational methods within its CVS pharmacy system, including its online pharmacy CVS.com and the dedicated pharmaceutical branch PharmaCare [2]
西维斯健康上涨5.94%,报66.0美元/股,总市值837.09亿美元